Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Indications for Paxlovid

    Assists in determining if Paxlovid (ritonovir-boosted nirmatrelvir) is appropriate therapy in a COVID positive adult patient.

    INSTRUCTIONS

    In the United States, Paxlovid (ritonovir-boosted nirmatrelvir), is currently availble under the Food and Drug Administration (FDA) Emergency Use Authorization (EUA). This drug status is subject to change. 

    When to Use

    Do you use Indications for Paxlovid Prescribing and want to contribute your expertise? Join our contributor team!

    Inclusion criteria

    Must fulfill all 5 to evaluate for Paxlovid

    Diagnostic Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights
    Centers for Disease Control and Prevention

    About the Creator

    The CDC is the leading national public health agency in the US. It focuses on infectious disease, food borne pathogens, environmental health, occupational safety and health, health promotion, injury prevention, and educational activities designed to improve public health. More information can be found on the CDC website.

    About the Creator
    Centers for Disease Control and Prevention